| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848679 | American Journal of Kidney Diseases | 2012 | 9 Pages |
Abstract
The efficacy of citrate and heparin anticoagulation for CRRT was similar. However, citrate anticoagulation decreased the risk of bleeding with no significant increase in the incidence of metabolic alkalosis. We recommend citrate as an anticoagulation agent in patients who require CRRT but are at high risk of bleeding.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mei-Yi MD, Yung-Ho MD, Chyi-Huey PhD, Yuh-Feng MD, Chih-Hsiung MD, PhD, Ka-Wai MD, MS,